We have been a pioneer in developing and producing viral vectors since 1994.
We are grounded in the Mérieux family’s legacy of biology and vaccine expertise since 1897.
We are a pure CDMO player contributing to the success of your immunotherapy and gene therapy innovations.
first viral vector facility in Europe
3 facilities (France & USA)
>25 years of experience
in viral vectors (manufacturing)
Fill & up to 10 000 vials/batch
ABL Your solution provider
Developing and manufacturing viral vectors for over 25 years
We had our first facility GMP certified in 1995.
We produce a wide range of viral vectors: Vaccinia, MVA, Adeno, Measles, ORF, Arenavirus, AAV and others.
From the early clinical phases, we consider the cost to the patients.
Innovative treatments must be affordable to respond to unmet medical needs.
To help you bring sustainable solutions to the market, we do not hesitate to test emerging innovations and cutting-edge technologies.
Dedicated project management
An open and mutual collaboration with you and your team is key to meet your project objectives and overcome technical challenges.
For each project, we assign a dedicated Project Manager (PM) who will be your main point of contact throughout the collaboration.
The PM supervises each step of the process, from project kick off, technical meetings to daily management of the multidisciplinary teams working on your project.
To provide you with the best quality services, we ensure continuous training and improvement of our ways of working.
Effective quality control capabilities essential for your success
Within an international competitive environment, right first time and in due time is critical for a successful submission, approval and launching.
In close collaboration with your team we will design and execute a detailed and robust process and analytical development plan, phase appropriate, accordingly to your product specification and overall project milestones. You can rely on our extensive experience with dossier submission and interaction with major health authorities. We generate all the necessary data package to make your discussion with health authorities a success.
Flexibility within our contracts
Our contracts are based on milestones achievements.
We will facilitate tech transfer to another site if required. We acknowledge that you need flexibility to support a potential licensing out strategy.
Transparency, including on pricing revision indexation, is a key word at ABL Fast into Clinic: ABL is organized to implement a lean and seamless process to minimize the timing from RFP reception to delivery of first material you need, without compromising with the quality.
You are at the center of our strategic decisions.
We offer you an hollistic approach, including solutions beyond the product manufacturing.
You can rely on our skilled and passionate teams to make your CMC journey easier and faster to market.
Talented teams to deliver the highest level of services
People are key assets within ABL, we consider that skills and experience of our collaborators are critical to bring value to your projects.
We foster diversity and creativity.
We encourage the continuous improvement through:
The versatility and adaptability of our manufacturing team to meet timelines without compromising quality.
Cross fertilization between our sites to implement the best practices and to organize seamless and efficient tech transfer.
Continuous training of our technicians and engineers through partnership with recognized universities having development and manufacturing fab-labs.